Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
Differentiating clinically between Parkinson's disease (PD) and the atypical parkinsonian syndromes of Progressive supranuclear palsy (PSP), corticobasal syndrome (CBS) and multiple system atrophy (MSA) is challenging but crucial for patient management and recruitment into clinical trials. Beca...
Main Authors: | P.G. Foulds, O. Yokota, A. Thurston, Y. Davidson, Z. Ahmed, J. Holton, J.C. Thompson, H. Akiyama, T. Arai, M. Hasegawa, A. Gerhard, D. Allsop, D.M.A. Mann |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996111002579 |
Similar Items
-
Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
by: Makoto Hashimoto, et al.
Published: (2012-09-01) -
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
by: Chao Peng, et al.
Published: (2018-01-01) -
Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies
by: Ethan W. Hass, et al.
Published: (2021-08-01) -
Effects of α-synuclein on axonal transport
by: Laura A. Volpicelli-Daley
Published: (2017-09-01) -
Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
by: Omar El-Agnaf, et al.
Published: (2017-08-01)